Assessment of the anaerobic degradation of six active pharmaceutical ingredients

被引:41
|
作者
Musson, Stephen E. [2 ]
Campo, Pablo [3 ]
Tolaymat, Thabet [1 ]
Suidan, Makram [3 ]
Townsend, Timothy G. [2 ]
机构
[1] US EPA, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA
[2] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA
[3] Univ Cincinnati, Dept Civil & Environm Engn, Cincinnati, OH 45221 USA
基金
美国国家环境保护局;
关键词
Anaerobic degradation; Pharmaceutical; PPCP; Sorption; PERSONAL CARE PRODUCTS; COEFFICIENT K-D; AQUATIC ENVIRONMENT; TREATMENT PLANTS; MUSK FRAGRANCES; SEWAGE-SLUDGE; WASTE; ESTROGENS; BIODEGRADATION; DIGESTION;
D O I
10.1016/j.scitotenv.2009.11.042
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Research examined the anaerobic degradation of 17 alpha-ethynylestradiol, acetaminophen, acetylsalicylic acid, ibuprofen, metoprolol tartrate, and progesterone by methanogenic bacteria. Using direct sample analysis and respirometric testing, anaerobic degradation was examined with (a) each compound as the sole organic carbon source and (b) each compound at a lower concentration (250 mu g/L) and cellulose serving as the primary organic carbon source. The change in pharmaceutical concentration was determined following 7, 28, 56, and 112 days of anaerobic incubation at 37 degrees C. Only acetylsalicylic acid demonstrated significant degradation; the remaining compounds showed a mixture of degradation and abiotic removal mechanisms. Experimental results were compared with BIOWIN, an anaerobic degradation prediction model of the US Environmental Protection Agency. The BIOWIN model predicted anaerobic biodegradability of the compounds in the order: acetylsalicylic acid > metoprolol tartrate > ibuprofen > acetaminophen > 17 alpha-ethinylestradiol > progesterone. This corresponded well with the experimental findings which found degradability in the order: acetylsalicylic acid > metoprolol tartrate > acetaminophen > ibuprofen. Published by Elsevier BM.
引用
收藏
页码:2068 / 2074
页数:7
相关论文
共 50 条
  • [1] An automated workstation for forced degradation of active pharmaceutical ingredients
    Sims, JL
    Roberts, JK
    Bateman, AG
    Carreira, JA
    Hardy, MJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (03) : 884 - 892
  • [2] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    [J]. CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [3] Prequalification of active pharmaceutical ingredients
    [J]. WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [4] Prequalification of active pharmaceutical ingredients
    [J]. WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [5] Ball milling - a new concept for predicting degradation profiles in active pharmaceutical ingredients
    Kaiser, Reinhard P.
    Krake, Everaldo F.
    Backer, Laura
    Urlaub, Jonas
    Baumann, Wolfgang
    Handler, Norbert
    Buschmann, Helmut
    Beweries, Torsten
    Holzgrabe, Ulrike
    Bolm, Carsten
    [J]. CHEMICAL COMMUNICATIONS, 2021, 57 (90) : 11956 - 11959
  • [6] Relating Degradation of Pharmaceutical Active Ingredients in a Stream Network to Degradation in Water-Sediment Simulation Tests
    Honti, Mark
    Bischoff, Fabian
    Moser, Andreas
    Stamm, Christian
    Baranya, Sandor
    Fenner, Kathrin
    [J]. WATER RESOURCES RESEARCH, 2018, 54 (11) : 9207 - 9223
  • [8] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    [J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [9] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    [J]. ENVIRONMENTAL CHEMISTRY LETTERS, 2024,
  • [10] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    [J]. CHEMMEDCHEM, 2011, 6 (06) : 975 - 985